Ocutec Ltd Secure £1.5M Seed Funding Round
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Summary of the Deepbridge Explore Webinar
Simon Tutton, Regional Director (South West England and South Wales), Deepbridge Capital
As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund.
Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Professional Adviser to share his thoughts regarding the world of tax-efficient investments and assesses which relief is the trump card for advisers and clients.
SmallSpark Space Systems, the award-winning rocket propulsion innovation company, has announced the closure of a significant overfunding of its recent seed round, securing a commitment for an additional £1.1 million investment on top of the £500,000 scale-up investment raised last year. With additional Government research funding of £200,000 over the past 18 months, this brings the total capital the company has raised for its technologies to £2.2 million, led by Deepbridge Capital and government co-funding.
Hy-genie, a portfolio company within the Deepbridge Life Sciences EIS fund, was a worthy winner of Business Cloud's MedTech 50 innovation ranking last year - with the help from Alder Hey Children's Hospital in its progress.
Aegiq, a University of Sheffield spin-out developing networking technology that's secure in the quantum computing age, has raised £1.8 million in seed funding for its quantum photonics platform.
Deepbridge Capital and angel investors provided funds alongside High-Tech Gründerfonds, bringing Aegiq's total funding to date to £3.5 million. Aegiq is also considering funds to join a second seed round of funding.
Deepbridge has today (19 January 2022) announced that Pathfinder Medical, a portfolio company within the Deepbridge Life Sciences EIS fund has secured a further £8.5 million funding round, led by BGF and Parkwalk.
As of today (12th January 2022), we are happy to announce that the Deepbridge Capital Technology Growth EIS Fund has now deployed over £100m of capital.
GBI Magazine recently spoke to Sameer Kothari, Chief Executive Director of Zilico Ltd, to talk about his Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.